Re:NewCell AB (publ)
Stockholm Stock ExchangeTotal Valuation
Re:NewCell AB (publ) carries a market capitalization of 218.65M, placing it among publicly traded companies globally. Its enterprise value stands at 3.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 218.65M |
| Enterprise Value | 3.65B |
Share Statistics
Re:NewCell AB (publ) currently has 41.25M shares outstanding.
| Shares Outstanding | 41.25M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 12.76, and the price-to-book ratio stands at -2.90.
| PE Ratio | N/A |
| PS Ratio | 12.76 |
| PB Ratio | -2.90 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | -25.59 |
| P/OCF Ratio | -7.67 |
Enterprise Valuation
| EV / Sales | 17.79 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 83.77 |
Financial Position
Re:NewCell AB (publ) maintains a current ratio of 1.38, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 142.06, indicating elevated leverage, while an interest coverage ratio of -8.74 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.38 |
| Quick Ratio | 0.36 |
| Debt / Equity | 142.06 |
| Debt / EBITDA | -3.08 |
| Interest Coverage | -8.74 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -21.91 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.34 |
Taxes
| Income Tax | -1.20M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Re:NewCell AB (publ)'s stock has declined approximately -93.29962% over the past 52 weeks. The 50-day moving average sits at 5.30, while the 200-day moving average is 5.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -93.29962% |
| 50-Day Moving Average | 5.30 |
| 200-Day Moving Average | 5.31 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Re:NewCell AB (publ) generated 205.18M in revenue and converted that into -401.35M in net income, yielding earnings per share of -10.11. EBITDA reached -368.29M, while operating income came in at -368.29M.
| Revenue | 205.18M |
| Gross Profit | -83.07M |
| Operating Income | -368.29M |
| Pretax Income | -402.54M |
| Net Income | -401.35M |
| EBITDA | -368.29M |
| EBIT | -368.29M |
| Earnings Per Share (EPS) | -10.11 |
Balance Sheet
Re:NewCell AB (publ) holds 102.80M in cash and equivalents against 1.13B in total debt, resulting in a net debt position of 716.60M. Total book value stands at -901.90M, with working capital of 109.50M providing operational flexibility.
| Cash & Cash Equivalents | 102.80M |
| Total Debt | 1.13B |
| Net Debt | 716.60M |
| Equity (Book Value) | -901.90M |
| Book Value Per Share | -23.38 |
| Working Capital | 109.50M |
Cash Flow
Re:NewCell AB (publ) produced -341.59M in operating cash flow over the past twelve months. After subtracting -236.24M in capital expenditures, free cash flow totaled -577.83M - equivalent to -14.98 per share.
| Operating Cash Flow | -341.59M |
| Capital Expenditures | -236.24M |
| Free Cash Flow | -577.83M |
| FCF Per Share | -14.98 |
Margins
Re:NewCell AB (publ) operates with a gross margin of -40.49, reflecting its pricing power and cost economics. The operating margin of -179.50 and net profit margin of -195.60 provide insight into operational efficiency.
| Gross Margin | -40.49 |
| Operating Margin | -179.50 |
| Pretax Margin | -196.19 |
| Profit Margin | -195.60 |
| EBITDA Margin | -179.50 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -20.74 |
| FCF Yield | -3.91 |
Scores
Re:NewCell AB (publ) posts an Altman Z-Score of 0.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.22 |